EODData

FRA, 9Y4: RYVU THERAPEUTICS ZY-40

21 Jul 2026
LAST:

3.205

CHANGE:
 0.13
OPEN:
3.205
HIGH:
3.205
ASK:
0.000
VOLUME:
0
CHG(%):
3.75
PREV:
3.330
LOW:
3.205
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
21 Jul 263.2053.2053.2053.2050
20 Jul 263.3303.3303.3303.3300
17 Jul 263.2903.2903.2903.2900
16 Jul 263.3653.3653.3653.3650
15 Jul 263.4303.4303.4303.4300
14 Jul 263.5153.5153.5153.5150
13 Jul 263.3653.3653.3653.3650
10 Jul 263.2603.2603.2603.2600
09 Jul 263.2703.2703.2703.2700
08 Jul 263.3703.3703.3703.3700

PROFILE

Name:RYVU THERAPEUTICS ZY-40
About:Ryvu Therapeutics S.A., a clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally. The company's lead candidate, RVU120, is a CDK8 and CDK19 kinase inhibitor in Phase 2 clinical trial with potential to treat monotheraphy, combination therapy, monotherapy, and myelofibrosis. It also develops SEL24/MEN1703, a dual PIM and FLT3 kinase inhibitor licensed to the Menarini Group that is in study start-up for Phase 2 clinical trial for the treatment of diffuse large b-cell lymphoma and acute myeloid leukemia. In addition, the company's early pipeline candidates include candidates in the areas of kinases, synthetic lethality, immunometabolism, and immuno-oncology. It has collaborations with BioNTech SE to advance small molecule programs to target immune modulation in cancer and other disease areas; Exelixis Inc. for the development of targeted therapies based on Ryvu's STING agonist technology. The company was formerly known as Selvita S.A. and changed its name to Ryvu Therapeutics S.A. in October 2019. Ryvu Therapeutics S.A. was founded in 2007 and is headquartered in Kraków, Poland.
Sector:Healthcare
Industry:Biotechnology
Address:Leona Henryka Sternbacha 2, Kraków, Poland, 30-394
Website:https://ryvu.com
ISIN:PLSELVT00013
LEI:2594003WO9Q9HHAFL031

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-0.74 
PEG Ratio:0.01 
Price to Sales:1.21 
Price to Book:1.06 
Profit Margin:-1.00 
Operating Margin:-1.48 
Return on Assets:-0.20 
Return on Equity:-1.10 
Revenue:62.25M 
Shares:23.12M 
Market Cap:74.09M 

TECHNICAL INDICATORS

MA5:3.323.7%
MA10:3.344.2%
MA20:3.292.8%
MA50:3.7617.4%
MA100:4.6244.3%
MA200:5.3567.0%
RSI14:51.29
WPR14:-100.00 
MTM14:-0.13
ROC14:-0.04 
ATR:0.11 
Week High:3.529.7%
Week Low:3.210.0%
Month High:3.5410.3%
Month Low:3.1167.0%
Year High:7.29127.5%
Year Low:3.113.1%
Volatility:60.92